Five things to know:
1. Total operating revenue for the six-month period ended Dec. 31 was $193.2 million, which was 4.2% higher than the same period last year. Operating expenses were $158.5 million, a number 3.4% greater than the same period last year.
2. Operating income estimates came in $5.1 million higher than budgeted. The -1% operating budget was favorable to the budgeted amount of -1.1%, the report said.
3. Total operating revenue was $115.5 million (2.5%) above budget, which was driven by net patient service revenue ($40.7 million), insurance premium revenue ($33.1 million) and other revenue ($30.8 million), mainly due to higher 340B contract pharmacy revenue.
4. Total operating expenses were $110.4 million (2.3%) higher than budgeted. The increase was driven by unfavorable variance for salaries and wages ($44 million), supplies ($19.9 million), drugs ($45.6 million) and other expenses ($36.4 million). These were partially offset by variance for insurance services medical expense ($22.5 million). Temporary staffing costs, included in the other expense line item, were $30.5 million less than the prior year.
5. Clinical operations experienced a $80.6 million loss, which was $12.8 million higher than budgeted. Jefferson’s insurance operations saw an operating gain of $18.6 million, which was $4.6 million favorable to the budget. Including risk-based contracts of hospital providers, the insurance component saw an operating gain of $86.6 million, which was $35.7 million favorable to budget, the report said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
